Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Helge L. Waldum, Gunnar Qvigstad, Reidar Fossmark, Per M. Kleveland & Arne K. Sandvik. (2010) Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scandinavian Journal of Gastroenterology 45:4, pages 389-394.
Read now
Read now
M. Valentini, F. Bortoluzzi, C. Cernigoi, G. Toffoli, E. Bertolissi, R. Cannizzaro, M. Sozzi & M. Fornasarig. (1993) Effect of Short- and Long-Term Treatment with Omeprazole on Cell Cycle Distribution in the Gastric Mucosa: Results of a Flow Cytometric Study. Scandinavian Journal of Gastroenterology 28:7, pages 617-621.
Read now
Read now
K. E. L. McColl, A. M. El Nujumi, C. A. Dorrian, A. M. I. Macdonald, G. M. Fullarton & J. Harwood. (1992) Helicobacter pylori and Hypergastrinaemia during Proton Pump Inhibitor Therapy. Scandinavian Journal of Gastroenterology 27:2, pages 93-98.
Read now
Read now
L. Lundell, L. Backman, P. Ekström, L.-K. Enander, S. Falkmer, O. Fausa, L. Grimelius, N. Havu, T. Lind, H. Lönroth, S. Sandmark, B. Sandzén, P. Unge & I. H. Westin. (1991) Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine. Scandinavian Journal of Gastroenterology 26:3, pages 248-256.
Read now
Read now
L. C. Baak, I. Biemond, J.B.M. J. Jansen & C.B.H. W. Lamers. (1991) Repeated Intravenous Bolus Injections of Omeprazole: Effects on 24-Hour Intragastric pH, Serum Gastrin, and Serum Pepsinogen A and C. Scandinavian Journal of Gastroenterology 26:7, pages 737-746.
Read now
Read now
Articles from other publishers (42)
Joe D. Pagan, Laura Petroski-Rose, Alana Mann & Ashlee Hauss. (2020) Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses. Journal of Equine Veterinary Science 86, pages 102851.
Crossref
Crossref
Ronit Zilberboim & Adrianne Bendich. 2015. Preventive Nutrition. Preventive Nutrition
553
595
.
Yu-Xiao Yang. (2012) Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism. Current Gastroenterology Reports 14:6, pages 473-479.
Crossref
Crossref
Marcus Zulian Teixeira. (2011) Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude. Homeopathy 100:3, pages 148-156.
Crossref
Crossref
Weijiang Zhang, Jingtao Wu & Stuart N. Atkinson. (2009) Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects. The Journal of Clinical Pharmacology 49:4, pages 444-454.
Crossref
Crossref
M. SINGH, G. DHINDSA, S. FRIEDLAND & G. TRIADAFILOPOULOS. (2007) Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Alimentary Pharmacology & Therapeutics 26:7, pages 1051-1061.
Crossref
Crossref
Yu–Xiao Yang, Sean Hennessy, Kathleen Propert, Wei–Ting Hwang, Alireza Sedarat & James D. Lewis. (2007) Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer. Gastroenterology 133:3, pages 748-754.
Crossref
Crossref
M. F. Erdogan, A. Gursoy & M. Kulaksizoglu. (2014) Long-term effects of elevated gastrin levels on calcitonin secretion. Journal of Endocrinological Investigation 29:9, pages 771-775.
Crossref
Crossref
Michael Stock & Florian Otto. (2005) Gene deregulation in gastric cancer. Gene 360:1, pages 1-19.
Crossref
Crossref
L. D. Allgood, J. M. Grender, M. J. Shaw & D. A. Peura. (2005) Comparison of Prilosec OTCTM (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn. Journal of Clinical Pharmacy and Therapeutics 30:2, pages 105-112.
Crossref
Crossref
Hyung-Keun Roh, Pum-Soo Kim, Don-Haeng Lee, Gunnel Tybring, Mohamed Sagar, Chang-Shin Park, Rein Seensalu & Leif Bertilsson. (2004) Omeprazole Treatment of Korean Patients: Effects on Gastric pH and Gastrin Release in Relation to CYP2C19 Geno- and Phenotypes. Pharmacology and Toxicology 95:3, pages 112-119.
Crossref
Crossref
Anamika Pradeep, Chandan Sharma, Pradeep Sathyanarayana, Chris Albanese, John V Fleming, Timothy C Wang, M Michael Wolfe, Kenneth M Baker, Richard G Pestell & Basabi Rana. (2004) Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells. Oncogene 23:20, pages 3689-3699.
Crossref
Crossref
DHRUV SUD, IAN M. P. JOSEPH & DENISE KIRSCHNER. (2011) PREDICTING EFFICACY OF PROTON PUMP INHIBITORS IN REGULATING GASTRIC ACID SECRETION. Journal of Biological Systems 12:01, pages 1-34.
Crossref
Crossref
Jean-Francois Marier, Marie-Claude Dubuc, Eric Drouin, Fernando Alvarez, Murray P. Ducharme & Jean-Louis Brazier. (2004) Pharmacokinetics of Omeprazole in Healthy Adults and in Children with Gastroesophageal Reflux Disease. Therapeutic Drug Monitoring 26:1, pages 3-8.
Crossref
Crossref
Giovanni Vitale, Antonio Ciccarelli, Michele Caraglia, Maurizio Galderisi, Riccardo Rossi, Salvatore Del Prete, Alberto Abbruzzese & Giovanni Lupoli. (2002) Comparison of Two Provocative Tests for Calcitonin in Medullary Thyroid Carcinoma: Omeprazole vs Pentagastrin. Clinical Chemistry 48:9, pages 1505-1510.
Crossref
Crossref
S A Watson, T M Morris, D F McWilliams, J Harris, S Evans, A Smith & P A Clarke. (2002) Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. British Journal of Cancer 87:5, pages 567-573.
Crossref
Crossref
Jia-Qing Huang & Richard H. Hunt. (2001) Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice & Research Clinical Gastroenterology 15:3, pages 355-370.
Crossref
Crossref
K. H. Moore, P. Barry, J. Burn & G. Falk. (2001) Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study. Diseases of the Esophagus 14:1, pages 17-22.
Crossref
Crossref
Kenneth E.L. McColl, Derek Gillen & Emad El-Omar. (2000) The role of gastrin in ulcer pathogenesis. Best Practice & Research Clinical Gastroenterology 14:1, pages 13-26.
Crossref
Crossref
Thjodleifsson & Cockburn. (1999) Review article: rabeprazole’s tolerability profile in clinical trials. Alimentary Pharmacology & Therapeutics 13, pages 17-23.
Crossref
Crossref
Sanduleanu, Stridsberg, Jonkers, Hameeteman, Biemond, Lundqvist, Lamers & Stockbrügger. (1999) Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Alimentary Pharmacology & Therapeutics 13:2, pages 145-153.
Crossref
Crossref
Hiroyuki MIKI, Hirotaka YAMADA, Nozomi YOSHIKAWA & Keiji MITAMURA. (1999) Effect of Omeprazole Ingestion on Healing of Gastric Ulcers and Serum Gastrin Concentration in Rats. The Showa University Journal of Medical Sciences 11:2, pages 105-114.
Crossref
Crossref
Jia-Qing Huang & Richard H. Hunt. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors
63
78
.
Murat Faik Erdoğan, Sevim Güllü, Nilgün Başkal, Ali Riza Uysal, Nuri Kamel & Gürbüz i Erdoğan. (1997) Omeprazole: Calcitonin Stimulation Test for the Diagnosis Follow-Up and Family Screening in Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism 82:3, pages 897-899.
Crossref
Crossref
Yoseph Caraco, Per-Olaf Lagerstrom & Alastair J.J. Wood. (1996) Ethnic and genetic determinants of omeprazole disposition and effect*. Clinical Pharmacology & Therapeutics 60:2, pages 157-167.
Crossref
Crossref
Akira Tari, Masanori Hamada, Toshiki Kamiyasu, Youichi Fukino, Masaharu Sumii, Ken Haruma, Koji Sumii, Masaki Inoue & Goro Kajiyama. (1996) Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients. Journal of Gastroenterology 31:2, pages 167-170.
Crossref
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
Crossref
Bengt Hallerbäck, Peter Unge, Lasse Carling, Björn Edwin, Hans Glise, Nilu Havu, Ebbe Lyrenäs & Kjell Lundberg. (1994) Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 107:5, pages 1305-1311.
Crossref
Crossref
Vincenzo Savarino, Giuseppe Sandro Mela, Patrizia Zentilin, Patrizia Cutela, Maria Raffaella Mele, Daniele Perilli, Ambrogio Vassallo, Adriana Zambotti, Carlo Mansi & Guido Celle. (1994) Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. Digestive Diseases and Sciences 39:7, pages 1473-1482.
Crossref
Crossref
J L Meijer, J B Jansen, L F Crobach, I Biemond & C B Lamers. (1993) Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.. Gut 34:9, pages 1186-1190.
Crossref
Crossref
R. COLLINS, S. BEATTIE, H. X. XIA & C. O'MORAIN. (2007)
Short report: high‐dose omeprazole and amoxycillin in the treatment of
Helicobacter
pylori‐associated duodenal ulcer
. Alimentary Pharmacology & Therapeutics 7:3, pages 313-315.
Crossref
Crossref
Robert D. Shamburek & Mitchell L. Schubert. (1993) Pharmacology of gastric acid inhibition. Baillière's Clinical Gastroenterology 7:1, pages 23-54.
Crossref
Crossref
J. Calam, R. A. Goodlad, C. Y. Lee, B. Ratcliffe, M. E. Coates, G. W. H. Stamp & N. A. Wright. 1993. Helicobacter pylori and Gastroduodenal Pathology. Helicobacter pylori and Gastroduodenal Pathology
90
97
.
Robert D. Shamburek & Mitchell L. Schubert. (1992) CONTROL OF GASTRIC ACID SECRETION. Gastroenterology Clinics of North America 21:3, pages 527-550.
Crossref
Crossref
Roger G. Berlin. (1991) Omeprazole: Gastrin and gastric data (August 1991). Digestive Diseases and Sciences 36:10, pages 1501-1502.
Crossref
Crossref
L C Baak, J B Jansen, I Biemond & C B Lamers. (1991) Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.. Gut 32:9, pages 977-982.
Crossref
Crossref
Hans Simon Merki, Clive H. Wilder-Smith, Robert P. Walt & Fred Halter. (1991) The cephalic and gastric phases of gastric secretion during H2-antagonist treatment. Gastroenterology 101:3, pages 599-606.
Crossref
Crossref
Tiziana D'Adda, Francesco P. Pilato, Marco Lazzaroni, Flavio Robutti, Gabriele Bianchi-Porro & Cesare Bordi. (1991) Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. Gastroenterology 100:6, pages 1563-1570.
Crossref
Crossref
John A. Oates, Alastair J.J. Wood & Paul N. Maton. (1991) Omeprazole. New England Journal of Medicine 324:14, pages 965-975.
Crossref
Crossref
T. Lind, C. Cederberg, M. Olausson & L. Olbe. (1990) 24-Hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology 99:6, pages 1593-1598.
Crossref
Crossref
C. H. Wilder-Smith, T. Ernst, M. Gennoni, B. Zeyen, F. Halter & H. S. Merki. (1990) Tolerance to oral H2-receptor antagonists. Digestive Diseases and Sciences 35:8, pages 976-983.
Crossref
Crossref
H. KOOP, M. KLEIN & R. ARNOLD. (2007) Serum gastrin levels during long‐term omeprazole treatment. Alimentary Pharmacology & Therapeutics 4:2, pages 131-138.
Crossref
Crossref